BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2007
View Archived Issues
Recent patents impart new therapeutic agents for cancer
Read More
Recent Bristol-Myers Squibb patent describes new agents for thrombotic disorders
Read More
Mechanism behind orlistat's antitumor activity explored
Read More
New compounds targeting autoimmune diseases claimed in recent Mitsubishi Pharma patent
Read More
pSivida reflects on transition to drug delivery company
Read More
Fast track designation for Generx
Read More
Enrollment open in women-only drug-eluting stent trial
Read More
TAK-491 enters phase III in U.S. and Europe
Read More
Antares Pharma and Jazz sign product development and license agreement
Read More
GeoVax begins two new AIDS vaccine clinical trials
Read More
Salix submits NDA for twice daily antiinflammatory balsalazide
Read More
Cortex to resume Alzheimer-PET scan study with higher dose levels
Read More
Roche and Trimeris begin integrase inhibitor and once-daily Fuzeon combination trial
Read More
Avastin recommended for E.U. approval in NSCLC
Read More
Celsentri recommended for approval in E.U.
Read More
Sugammadex MAA accepted for review
Read More
Galvus receives European recommendation for approval
Read More
CHMP recommends E.U. approval of Aclasta for postmenopausal osteoporosis
Read More
Exelon Patch recommended for E.U. approval
Read More
Yondelis recommended for E.U. approval in soft tissue sarcoma
Read More
EMEA recommends approval for Merz's Xeomin
Read More
LG Life Sciences synthesizes novel, potent DPP-IV inhibitors
Read More